comparemela.com
Home
Live Updates
Acoramidis Shows Encouraging Results in ATTR Cardiomyopathy
Acoramidis Shows Encouraging Results in ATTR Cardiomyopathy
Acoramidis Shows Encouraging Results in ATTR Cardiomyopathy
Lead author of the ATTRibute-CM trial says it was "robustly positive," and shows "the tantalizing possibility of genuine clinical improvements" for this progressive and fatal condition.
Related Keywords
France ,
Japan ,
United Kingdom ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Creteil ,
France General ,
Bio Pharma ,
Julian Gillmore ,
Bridgebio Pharma ,
Henri Mondor ,
European Society Of Cardiology ,
Drug Administration ,
Paris East Creteil University ,
Pfizer ,
University College London Centre For Amyloidosis ,
Congress On ,
York Heart Association ,
European Society ,
University College London Centre ,
New York Heart Association ,
Thibaud Damy ,
Hospital Henri Mondor ,
Cardiomyopathy ,
Heart ,
Heart Failure ,
Europe ,
European ,
Quality Of Life ,
Pol ,
Ealth Related Quality Of Life ,
Rqol ,
B Type Natriuretic Peptide ,
Want ,
Amyloidosis ,